These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37335827)

  • 21. Cardiovascular disease, obesity, and type 2 diabetes in children born after assisted reproductive technology: A population-based cohort study.
    Norrman E; Petzold M; Gissler M; Spangmose AL; Opdahl S; Henningsen AK; Pinborg A; Tiitinen A; Rosengren A; Romundstad LB; Wennerholm UB; Bergh C
    PLoS Med; 2021 Sep; 18(9):e1003723. PubMed ID: 34491995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of common weight loss plans on diabetes mellitus and cardiovascular risk factors.
    Wołos-Kłosowicz K; Bandurska-Stankiewicz E
    Prim Care Diabetes; 2022 Apr; 16(2):252-256. PubMed ID: 34802979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Davis TM
    Intern Med J; 2010 Apr; 40(4):286-92. PubMed ID: 19323700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The American Heart Association Ideal Cardiovascular Health and Incident Type 2 Diabetes Mellitus Among Blacks: The Jackson Heart Study.
    Effoe VS; Carnethon MR; Echouffo-Tcheugui JB; Chen H; Joseph JJ; Norwood AF; Bertoni AG
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28637777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Risk Stratification and its Determinants Among Patients with Type 2 Diabetes Mellitus.
    Deb P; Mohanty IR; Rai S
    J Assoc Physicians India; 2020 Mar; 68(3):90. PubMed ID: 32138498
    [No Abstract]   [Full Text] [Related]  

  • 27. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
    Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of type 2 diabetes for prevention of cardiovascular disease. An expert opinion of the Italian Diabetes Society.
    Napoli R; Formoso G; Piro S; Targher G; Consoli A; Purrello F
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1926-1936. PubMed ID: 32928628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Young at heart. For people with type 2 diabetes, cardiovascular disease is enemy No. 1.
    Curry A
    Diabetes Forecast; 2014 Dec; 67(12):68-9. PubMed ID: 25872369
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013).
    Jung CH; Chung JO; Han K; Ko SH; Ko KS; Park JY;
    Cardiovasc Diabetol; 2017 Jan; 16(1):1. PubMed ID: 28057001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis.
    Xie W; Wang Y; Xiao S; Qiu L; Yu Y; Zhang Z
    BMJ; 2022 Sep; 378():e070244. PubMed ID: 36130740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk in type 1 and type 2 diabetes: Differences, similarities and insights.
    Victoria EOM; Doménech CV
    Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(7):455-457. PubMed ID: 36084986
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
    Fox CS; Golden SH; Anderson C; Bray GA; Burke LE; de Boer IH; Deedwania P; Eckel RH; Ershow AG; Fradkin J; Inzucchi SE; Kosiborod M; Nelson RG; Patel MJ; Pignone M; Quinn L; Schauer PR; Selvin E; Vafiadis DK;
    Circulation; 2015 Aug; 132(8):691-718. PubMed ID: 26246173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New opportunities of antithrombotic therapy in patients with type 2 diabetes mellitus and stable coronary heart disease for reducing the cardiovascular risk and cardiovascular complications: THEMIS, THEMIS-PCI trials].
    Kalashnikov VI; Michurova MS
    Ter Arkh; 2022 Nov; 94(10):1204-1210. PubMed ID: 36468996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?
    Truong UT; Maahs DM; Daniels SR
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1(Suppl 1):S11-21. PubMed ID: 22650220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal association of electrocardiogram abnormalities with major adverse cardiac events in people with Type 2 diabetes: the Hoorn Diabetes Care System cohort.
    Harms PP; Elders PPJM; Rutters F; Lissenberg-Witte BI; Tan HL; Beulens JWJ; Nijpels G; van der Heijden AA;
    Eur J Prev Cardiol; 2023 Jun; 30(8):624-633. PubMed ID: 36625405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
    Masmiquel L; Leiter LA; Vidal J; Bain S; Petrie J; Franek E; Raz I; Comlekci A; Jacob S; van Gaal L; Baeres FM; Marso SP; Eriksson M;
    Cardiovasc Diabetol; 2016 Feb; 15():29. PubMed ID: 26864124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and coronary artery disease: not just a risk factor.
    Grant PJ; Cosentino F; Marx N
    Heart; 2020 Sep; 106(17):1357-1364. PubMed ID: 32499237
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
    Segar MW; Patel KV; Vaduganathan M; Caughey MC; Jaeger BC; Basit M; Willett D; Butler J; Sengupta PP; Wang TJ; McGuire DK; Pandey A
    Diabetologia; 2021 Jul; 64(7):1583-1594. PubMed ID: 33715025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies.
    Avogaro A; Barillà F; Cavalot F; Consoli A; Federici M; Mancone M; Paolillo S; Pedrinelli R; Perseghin G; Perrone Filardi P; Scicali R; Sinagra G; Spaccarotella C; Indolfi C; Purrello F
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1671-1690. PubMed ID: 33994263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.